Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?

Figure 3 Pathologically confirmed intrahepatic cholangiocarcinoma in a 47-year-old man. A: A 53.2-mm hypointense mass is seen on the precontrast image; B: The image shows rim-like hyperenhancement in the arterial phase; C: Peripheral “washout” in the portal venous phase; D: Targetoid appearance in the hepatobiliary phase; and E: Target sign in diffusion-weighted imaging; F: The mass was confirmed as intrahepatic cholangiocarcinoma at 200 × magnification after hematoxylin-eosin staining.